Medicine
Renal Replacement Therapy Modalities for Acute Kidney Injury
Quick fact
Continuous renal replacement therapy (CRRT) runs 24 hours a day and is typically used for unstable ICU patients, whereas intermittent hemodialysis is done over about 4 hours and is preferred for stable patients.
Why this is interesting
When the kidneys suddenly fail, doctors must quickly choose how to replace their function—but did you know that there are several very different ways to do this, each with its own advantages and trade-offs?
Read the full explanation
Understanding Renal Replacement Therapy Modalities for Acute Kidney Injury
Imagine your kidneys as a high-tech water filtration system that removes waste and extra fluid from your blood. When they fail suddenly (acute kidney injury), you need an external machine to do that job. The three main options are: - Intermittent Hemodialysis (IHD): Blood is pumped through a filter (dialyzer) for a few hours, several times a week. It's like a powerful but quick filter that does a lot of work in a short time. - Continuous Renal Replacement Therapy (CRRT): This is a gentler, slower version that runs 24/7. It uses a machine similar to hemodialysis but with lower blood flow and longer duration. It's like a slow drip filter that's easier on a very sick patient. - Peritoneal Dialysis (PD): This uses the patient's own belly lining (peritoneum) as a natural filter. A sterile solution is dripped into the abdomen, left for a while, then drained. It's like using a reusable bag to soak up waste. All these methods remove waste products and excess fluid, but they differ in speed, convenience, and patient tolerance.
A deeper explanation
The key to understanding RRT is that it mimics the kidney's two main functions: diffusion (removing small waste molecules) and convection (removing fluid and larger molecules). IHD relies mainly on diffusion: a concentration gradient between blood and dialysate drives waste across a semipermeable membrane. It's efficient but can cause rapid shifts in fluid and electrolytes, leading to low blood pressure or muscle cramps. CRRT uses both diffusion and convection (ultrafiltration) but at a slower pace. This keeps fluid and solute levels stable, making it ideal for patients with unstable blood pressure, severe fluid overload, or brain injury. The trade-off is that it requires prolonged patient immobility and anticoagulation to prevent clotting in the filter. PD works via diffusion across the peritoneum, which acts as a natural membrane. It's simpler and doesn't require a machine or vascular access, but it's less efficient and carries risks of infection and protein loss. The choice of modality depends on the patient's hemodynamic status, need for metabolic control, resource availability, and contraindications (e.g., recent abdominal surgery for PD). Understanding these mechanisms helps clinicians tailor therapy to the individual patient, balancing effectiveness with safety.